ibrutinib,rituximab
abbvie,janssen
['mantle,(-dismantle)', 'lymsm', 'lymphoma']
ibrutinib combined w/ standard 1l treatment or as substitute for asct in younger pts w/ mantle cell lymphoma: results from randomized triangle trial by the european mcl network [sun, dec 11, 2022: 2-4p, hall e] dreyling etal. plenary 1 #ash22 #lymsm #bmtsm 
Views my own. VP Clinical Partnerships @TempusLabs #PrecisionMedicine #mmsm #lymsm @ASCO BOD (19-23) #CCC19 @COVID19nCCC https://t.co/ckNS2CepBH